Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Febrile Neutropenia 2Neoplasms 1Hematologic Neoplasms 1Cystectomy 1

Interventions

Meropenem 7Vancomycin 6Filgrastim 5Ceftazidime 5pegylated granulocyte colony-stimulating factor 4Cefepime 4pegfilgrastim 3Levofloxacin 3Ciprofloxacin 3Amikacin 3Teicoplanin 2Piperacillin, Tazobactam Drug Combination 2Linezolid 2Interleukin 1 Receptor Antagonist Protein 2Amoxicillin-Potassium Clavulanate Combination 2ceftolozane, tazobactam drug combination 1Vaccination 1Therapeutics 1Tazobactam 1TKN732 1Sodium Chloride 1Simvastatin 1Positron Emission Tomography Computed Tomography 1Pneumococcal Vaccines 1Piperacillin 1Ofloxacin 1NF protocol 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Micafungin 1Metronidazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Febrile Neutropenia × Linezolid × Clear all
NCT02732327 2017-07-21

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Forest Laboratories

Phase 2 Terminated
2 enrolled 2 charts
Classical hematology

Neoplasms, Febrile Neutropenia

NCT00035425 2009-12-01

Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection

Pfizer

Phase 3 Completed
120 enrolled
Classical hematology

Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡